FORA Capital’s Praxis Precision Medicines PRAX Stock Holding History

FORA Capital’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41M	Buy	4,205 +793	+23%	+$251K	0.1%	193
2026 Q1	$1.1M	Buy	+3,412	New	+$1.06M	0.08%	226

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

FORA Capital's PRAX Position: Q2 2026 in Review

FORA Capital increased its Praxis Precision Medicines (PRAX) stake by 23% in Q2 2026, buying an estimated $251K and bringing the position to 4,205 shares worth $1.41M. The position accounts for 0.1% of the portfolio, ranked #193.

FORA Capital first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

FORA Capital held 4,205 shares of Praxis Precision Medicines worth $1.41M as of Q2 2026.
FORA Capital bought 793 Praxis Precision Medicines shares in Q2 2026, an estimated $251K.
Praxis Precision Medicines made up 0.1% of FORA Capital's portfolio in Q2 2026, its #193 holding.
FORA Capital first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.